How many carbonic anhydrase inhibition mechanisms exist?

CT Supuran - Journal of enzyme inhibition and medicinal chemistry, 2016 - Taylor & Francis
Six genetic families of the enzyme carbonic anhydrase (CA, EC 4.2. 1.1) were described to
date. Inhibition of CAs has pharmacologic applications in the field of antiglaucoma …

Carbonic anhydrase and bacterial metabolism: a chance for antibacterial drug discovery

C Capasso, CT Supuran - Expert Opinion on Therapeutic Patents, 2024 - Taylor & Francis
ABSTRACT Introduction Carbonic anhydrases (CAs, EC 4.2. 1.1) play a pivotal role in the
regulation of carbon dioxide, bicarbonate, and hydrogen ions within bacterial cells, ensuring …

An overview of the alpha-, beta- and gamma-carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria?

C Capasso, CT Supuran - Journal of Enzyme Inhibition and …, 2015 - Taylor & Francis
Abstract Carbonic anhydrases (CAs, EC 4.2. 1.1) are metalloenzymes which catalyze a
simple but physiologically crucial reaction in all life Domains, the carbon dioxide hydration to …

[HTML][HTML] An overview of the bacterial carbonic anhydrases

CT Supuran, C Capasso - Metabolites, 2017 - mdpi.com
Bacteria encode carbonic anhydrases (CAs, EC 4.2. 1.1) belonging to three different genetic
families, the α-, β-, and γ-classes. By equilibrating CO2 and bicarbonate, these …

Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum—The η-carbonic anhydrases

S Del Prete, D Vullo, GM Fisher, KT Andrews… - Bioorganic & medicinal …, 2014 - Elsevier
The genome of the protozoan parasite Plasmodium falciparum, the causative agent of the
most lethal type of human malaria, contains a single gene annotated as encoding a carbonic …

Bacterial, fungal and protozoan carbonic anhydrases as drug targets

C Capasso, CT Supuran - Expert opinion on therapeutic targets, 2015 - Taylor & Francis
Introduction: The carbonic anhydrases (CAs, EC 4.2. 1.1), a group of ubiquitously expressed
metalloenzymes, are involved in numerous physiological and pathological processes, as …

Antibacterial carbonic anhydrase inhibitors: an update on the recent literature

CT Supuran, C Capasso - Expert Opinion on Therapeutic Patents, 2020 - Taylor & Francis
Introduction The clinically licensed drugs used as antibiotics prevent the microbial growth
interfering with the biosynthesis of proteins, nucleic acids, microorganism wall biosynthesis …

Experimental carbonic anhydrase inhibitors for the treatment of hypoxic tumors

CT Supuran - Journal of Experimental Pharmacology, 2020 - Taylor & Francis
Abstract Carbonic anhydrase (CA, EC 4.2. 1.1) isoforms IX and XII are overexpressed in
many hypoxic tumors as a consequence of the hypoxia inducible factor (HIF) activation …

Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors

G De Simone, V Alterio, CT Supuran - Expert opinion on drug …, 2013 - Taylor & Francis
Introduction: Carbonic anhydrases (CAs, EC 4.2. 1.1) exist as five genetically distinct
families (α, β, γ, δ and ζ) in organisms all over the phylogenetic tree. Due to the ubiquity of …

Sulfonamides and their isosters as carbonic anhydrase inhibitors

F Carta, CT Supuran, A Scozzafava - Future medicinal chemistry, 2014 - Taylor & Francis
Molecules containing the sulfonamide group (R-SO2NH2) as well as its structurally related
isosters, sulfamido (R-NH-SO2NH2) and sulfamato (RO-SO2NH2), constitute the most …